10.07.2015 Views

1E9Ct5D

1E9Ct5D

1E9Ct5D

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The role played by ANVISA is an important one, as ANVISA has the power to control and monitor theproducts and services that may pose risks to health.For the purposes of Law 9,782/99, goods and products subject to ANVISA’s health control andsanitary surveillance include:(i)(ii)(iii)(iv)(v)(vi)(vii)Human drugs, active ingredients of human drugs and other inputs, processes andtechnologies;Food products, including beverages, bottled waters and related inputs, packagingmaterials, food additives, organic contaminant levels, veterinary drugs and pesticidewaste;Cosmetics, personal care products and perfumes;Sanitizing products to be used in the clearing, disinfection or pest management in homes,hospitals and collective environments;Sets, reagents and inputs to be used in diagnosis;Medical, hospital, dental, hemotherapeutic and diagnostic imaging equipment andmaterials;Immunobiologicals and the related active ingredients, blood and blood products.Services subject to ANVISA’s health control and sanitary surveillance are any services related toemergency or routine ambulatory care, inpatient laboratory testing, therapy and diagnosis supportservices and services involving the use of new technology.Facilities, equipment, technology, environments and procedures involved in all stages of theproduction process of goods and services subject to health control and sanitary surveillance are alsosubject to ANVISA's control.But ANVISA’s scope of action is not limited to the products and services described above. ANVISAalso has the power to regulate other products and services with the purpose of controlling any risks tohuman health under the Brazilian Sanitary Surveillance System.Some of ANVISA’s primary duties are to grant companies operating permits (autorização defuncionamento de empresa - AFE) and register products (drugs/cosmetics/healthcare products).Registration of such products must be made exclusively by ANVISA, who is also responsible formaking any change in or revalidating, suspending or cancelling such registrations (art. 7, IX,paragraph 1 of Law 9,782/99).As a general rule, all such products must be registered. However, some exceptions are made.Products that are easy to be compounded in pharmacy laboratories, for example, are exempt fromregistration.114

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!